And our toolbox is expanding
Beneficial for prediabetes, type 2 diabetes, and metabolic syndrome patients
2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS guideline for the management of lower extremity peripheral artery disease: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
In TRIUMPH-4, dysesthesia (abnormal sensations: tingling, prickling, burning, numbness) was reported by 8,8% of participants in the 9 mg dose range and 20,9% of participants in the 12 mg dose range
Genetically modified Lactococcus lactis carrying Il-10 could impair colitis activity, showing that host-microbiota interaction and a compromised gut barrier could be leveraged to tread IBD 222
"I said, 'B*tch, where